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Abstract
Aims/hypothesis. Currently, three categories of cardio-
vascular autonomic nervous function measures are
used: classic Ewing-test measures, measures of heart-
rate variability (HRV), and measures of baroreflex
sensitivity (BRS). Little is known about the agreement
between these measures, and reference and reproduc-
ibility values for these measures have not been report-
ed within the same group.
Methods. As part of the Hoorn Study, 631 subjects
aged 50 to 75 participated in a study of autonomic
nervous function. Cardiac cycle duration (RR interval)
and continuous finger arterial pressure were measured
under three conditions: during spontaneous breathing,
during six deep breaths over 1 min, and during an ac-
tive change in position from lying to standing. From
these readings, ten measures of autonomic function
were assessed (mean heart rate, three Ewing test mea-
sures, five HRV measures and one BRS measure).
Results. Regression analysis in a healthy subgroup
(n=191) showed sex differences for two of the ten
measures and seven measures decreased with age.
Therefore, appropriate age-specific and sex-specific
reference values were calculated. Reproducibility
(n=39) of most measures was moderate, with a reli-
ability coefficient of around 50%. Agreement between
the measures of autonomic nervous function varied
greatly, between 0% and 87%. The HRV-power ratio
measure and the blood pressure changes in the lying-
to-standing test showed the lowest agreement with all
other measures.
Conclusion/Interpretation. This study provides age-
specific and sex-specific reference values for a wide
range of different autonomic function measures in an
elderly population. Agreement among the different
measures varied widely and reproducibility was only
moderate. [Diabetologia (2003) 46:330–338]
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the RR-interval spectrum between 0.04–0.12 Hz (ms2);
LF/(LF+HF), Ratio of low frequency power to the sum of low
and high frequency power in the RR-interval spectrum; Mean
NN, Mean of all sinus rhythm (normal-to-normal) RR inter-
vals (ms); NDM, Newly-diagnosed diabetes mellitus; NGT,
Normal glucose tolerance; RRmax, Maximal change in RR in-
terval after standing up (ms); RRmax/min, Maximal RR inter-
val between 15 s and 30 s after standing up divided by the
minimal RR interval within 15 s after standing up; SBP differ-
ence, Systolic blood pressure 1.5–2 minutes after standing up
minus systolic blood pressure in supine position (mmHg);
SDNN, Standard deviation of all sinus rhythm (normal-to-nor-
mal) RR intervals (ms).
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Autonomic changes in the heart and cardiovascular
system in diabetes mellitus occur as part of the wider
spectrum of autonomic neuropathy, which affects most
organs of the body, e.g. the gastrointestinal and the
genitourinary tracts, the sudomotor system involved in
sweat production, the eyes and the endocrine organs. It
is in the cardiovascular system that involvement of the
autonomic nervous system is most noticeable and most
easily assessed. Abnormalities can be detected in an
early, asymptomatic phase and in a non-invasive way.
Therefore, cardiovascular autonomic function tests
could play an important role in the early detection of
(diabetic) autonomic neuropathy. To some extent con-
sensus was obtained in the past on a number of tests to
assess cardiovascular autonomic function [1, 2]: the
so-called Ewing battery [3]. In addition, heart-rate
variability (HRV) and, more recently, the sensitivity of
spontaneous baroreflex control of the heart rate (baro-
reflex sensitivity, BRS), have been used to assess auto-
nomic dysfunction as well. It has been proposed that
these measures might be even more sensitive than the
Ewing battery [4, 5, 6, 7].
Among the standard cardiovascular autonomic
function tests, i.e. the Ewing battery, are the deep
breathing test, the lying-to-standing test, the Valsalva
manoeuvre and the sustained handgrip test [3]. These
Ewing test measures, and also HRV and BRS mea-
sures, are based on the autonomically mediated re-
sponse of the heart rate to changes in blood pressure.
Autonomic function has been reported to decrease in
relation to age [8, 9, 10, 11, 12, 13] and to differ be-
tween men and women [9, 14, 15]. Furthermore, dia-
betic patients have lower values on the Ewing battery
[3, 16, 17, 18, 19], of the spectral analysis of HRV [4,
16, 20, 21], and have a low BRS [5, 22] in comparison
with normal glucose tolerant control subjects. Besides
their application in the assessment of cardiovascular
autonomic function in diabetic patients, HRV and
BRS are used in cardiology for risk stratification after
myocardial infarction. Low HRV is associated with
mortality risk in post-myocardial infarction patients
[23, 24] and also in the general population [25, 26].
Also, autonomic neuropathy has been proposed to
play a role in the aetiology of cardiovascular disease
[27, 28, 29, 30, 31] and nephropathy [32, 33] in diabe-
tes. So far, the agreement between the autonomic
functions tests, their reproducibility and reference val-
ues have not been reported in a single study. This in-
formation will be valuable for clinical practice [34].
Subjects and methods
Study population: reference values and agreement. The Hoorn
Study is a prospective study of glucose tolerance and cardio-
vascular risk factors in a 50 to 75-year-old general Caucasian
population [35, 36, 37, 38]. In short, an age-, sex- and glucose-
tolerance-stratified sample of 708 subjects out of a cohort of
2484 was invited for a second 75-gram oral glucose tolerance
test within 3 to 5 weeks and requested to undergo an extensive
physical examination, including autonomic function tests, on
another day. Of this sample, 631 (89%) participated. Subjects
were classified according to the WHO criteria, based on the
mean values of the two oral glucose tolerance tests [39]: 288
had normal glucose tolerance (NGT), 169 had impaired glu-
cose tolerance (IGT), 95 had newly diagnosed diabetes
(NDM), and 79 subjects were known Type 2 diabetic patients
(KDM). For evaluating reference values only subjects with a
normal glucose tolerance were included. In addition, subjects
were excluded because of a self-reported history of neurologi-
cal disease (5 subjects), self-reported chronic obstructive pul-
monary disease (4 subjects), a history of cardiovascular dis-
ease (40 subjects) as assessed by means of a Dutch translation
of the London School of Hygiene and Tropical Medicine ques-
tionnaire [40]. Hypertensive subjects were also excluded; hy-
pertension was defined as current treatment with antihyperten-
sive drugs (49 subjects), mean systolic blood pressure greater
than or equal to 160 mmHg, and/or mean diastolic blood pres-
sure greater than or equal to 95 mmHg (36 subjects) based on
four blood pressure measurements. This resulted in a study
sample of 191 healthy subjects for the computation of the 
reference values. For the computation of agreement, the data
from the complete study sample of 631 subjects were used. Of
the 631 initial subjects, 43 were invited to participate in a re-
producibility study. The subjects were not selected on health
status, but were chosen in such a way to have a wide range of
ages and to have both normal glucose tolerance and diabetes.
Of the subjects 39 responded, and had a second set of measure-
ments taken within 3 weeks.
Individual data were missing for the following reasons: the
test schedule was not completed, the quality of the data was in-
sufficient for processing (a poor blood pressure signal or ar-
rhythmias) or there were more than 10% non-sinus beats in the
total number of recorded beats.
The study protocol was approved by the Ethics Committee
of the Vrije Universiteit Medical Centre. All study participants
gave their informed consent.
Participants were asked to refrain from smoking and drink-
ing coffee for 2 h prior to the assessment of cardiovascular au-
tonomic function. Tests took place between 8:30 am and
4:00 pm, at least 1 h after a light meal. Subjects were supine
resting in a quiet ambience, with a room temperature between
19 and 22 degrees Celsius. Cardiac cycle duration (RR inter-
val) and continuous finger arterial pressure were measured un-
der three conditions: (i) spontaneous breathing (Fig. 1), (ii) six
deep breaths over one minute (Fig. 2), and (iii) an active
change in position from lying to standing (Fig. 3). The correct
frequency of breathing of six breaths per minute was con-
trolled and dictated by oral and visual instructions of the inves-
tigator, who followed the beeps generated by the data-acquisi-
tion program. When off-line spectral analysis of the systolic
blood pressure data showed a clearly recognizable peak shifted
from the breathing frequency of 0.10 Hz by more than
0.02 Hz, the measurements were discarded. After each test a
resting period of at least 1 min was included, to prevent influ-
ences by previous test conditions.
During the tests, heart rate and blood pressure were continu-
ously recorded on a PC-based data-acquisition system. RR inter-
vals were obtained from a bipolar ECG chest-lead by a hardware
QRS detector with an accuracy of one millisecond. Blood pres-
sure was recorded continuously, using the Finapres method (Fin-
ger Arterial Blood Pressure, Ohmeda BP2000), digitally sam-
pled at 200 Hz, and off line low-pass filtered and down-sampled
to100 Hz. Beat-to-beat systolic blood pressure values were ob-
tained from this processed blood pressure signal by means of an
automatic procedure, which was verified by visual inspection.
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Ten parameters of cardiac autonomic function were de-
rived from the RR interval and systolic blood pressure re-
cordings obtained during the three respective conditions [37].
During spontaneous breathing over 3 min in the supine posi-
tion, the mean (mean NN) and the standard deviation
(SDNN) of all normal to normal, i.e. sinus rhythm, RR inter-
vals were computed [41]. Further, the power (variance) in the
low frequency (LF) band (0.04 to 0.12 Hz) and the power in
the high frequency (HF) band (0.12 to 0.40 Hz) were as-
sessed from all normal sinus rhythm RR intervals by spectral
analysis [41]. Also, the ratio of the LF power to the sum of
the LF and HF power was calculated [LF/(LF+HF)] [41].
From the recording during six deep breaths over 1 min in the
supine position, we measured the difference in maximum and
minimum RR interval duration during expiration and inspira-
tion, and averaged over the six consecutive breaths (EI differ-
ence) [3, 42]. Further, a measure of the sensitivity of the
spontaneous baroreflex control of heart rate, baroreflex sensi-
tivity (BRS) was calculated by means of cross-spectral analy-
sis. BRS was defined as the change in RR intervals caused by
changes in systolic blood pressure (ms/mmHg), and was esti-
mated as the gain of the transfer function between blood
pressure and RR interval changes [43, 44]. For the computa-
tion of the BRS only spectral components were used that
were within a defined band width (0.05–0.15 Hz) around the
Fig. 1A, B. A typical example of beat-to-beat variations in RR
intervals (RRI) and systolic blood pressure (SBP) during 3
minutes of spontaneous breathing in the supine position. Sub-
ject is a healthy woman aged 57 years. (A) Variability in the
time domain. (B) Variability in the frequency domain, ex-
pressed as power spectra; low frequency (LF) and high fre-
quency (HF) band are indicated by horizontal arrows
Fig. 2A–C. (A) Typical example of beat-to-beat variations in
RR intervals (RRI) and systolic blood pressure (SBP) during
one minute deep breathing at 6 breaths per minute. Same sub-
ject as in Figure 1. El difference is defined as the difference
between maximum and minimum RR interval (indicated by the
vertical arrow) averaged over 5–6 consecutive breaths; in this
case, 245 ms. (B) Power spectra of the above recordings. Note
that most of the power in RRI and SBP variations is concen-
trated in the one peak at breathing rate 0.1 Hz (6 per min). (C)
Transfer function between SBP and RRI variations. The aver-
age value of the bold part of the transfer gain function (conti-
nous line) is defined as the baroreflex sensitivity (BRS), in this
case, 11.1 ms/mmHg. Note the high coherence (dotted line) in
the respiratory band around 0.1 Hz (horizontal arrow)
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breathing frequency of six breaths per minute and with a
squared coherence (γ2) of 0.5 or higher. During an active
change in position from lying to standing, the maximal
change in RR interval (RRmax), defined as the difference be-
tween the mean RR interval during 1 min prior to standing up
and the minimum RR interval within 15 s after standing up,
was obtained [17]. Furthermore, we measured the maximum
RR interval between 15 and 30 s after standing up divided by
the minimum RR interval within 15 s after standing up
(RRmax/min) [45] and the systolic blood pressure difference
(SBP difference) after standing up calculated as the mean
over 30 s during 1.5 to 2 min after standing up, minus the
mean over 30 s prior to standing up [3].
Statistical Analysis. A normal distribution of SDNN, LF power,
HF power, EI difference, BRS, RRmax and RRmax/min values
was obtained by taking the natural logarithm. Subsequently, for
the presentation of the geometric means, standard deviations
and percentiles, ln-values were back-transformed. To assess the
possible influence of age and sex, the regression model was
used: Autonomic function measure =α+β1·age+β2·gender+β3·(age*sex) or submodels thereof, depending on the outcome
of the analysis; with age in decades and sex as a dichotomous
variable, 0=male and 1=female. Logarithmic (ln) transforma-
tion of SDNN, LF power, HF power, EI difference, BRS,
RRmax and RRmax/min was carried out to obtain normally dis-
tributed residuals. Reference values, defined as the 90% predic-
tion interval for individual predictions, were computed from the
estimated linear regression parameters, thus optimally using the
available measurements [38, 46].
To assess the agreement between the measures of autonom-
ic function, data from all 631 subjects were used. Spearman’s
correlation coefficient was computed between all ten mea-
sures. The computed reference values were applied and subse-
quently the percentage of findings concordant for autonomic
dysfunction was computed.
For the sample, which had duplicate measurements, the re-
liability coefficient (RC) and the coefficient of variation (CV)
were calculated by analysis of variance to obtain test-retest re-
liability [47].
RC=SD2between/(SD2between+SD2within)*100%, with high val-
ues of RC representing good reproducibility. CV=SDwithin/
meanboth measurements*100%, with low values representing good
reproducibility. For the ratio RRmax/min, the CV was comput-
ed using (meanboth measurements−1) as the nominator.
Two-tailed p values of less than 0.05 were considered sta-
tistically significant.
Results
Reference values (in reference sample, n=191). For
none of the autonomic function measures the interaction
term between age and sex was statistically significant.
After adjustment for age, the regression analysis showed
that LF power and EI difference were higher for men
than for women (Table 1 and 2). Therefore, sex-specific
reference values are presented for these measures. Of
the ten autonomic function parameters seven decreased
with increasing age, while for mean NN, LF/(LF+HF)
and SBP difference no association with age was ob-
served. Therefore, we calculated age-specific reference
values for SDNN, LF power, HF power, EI difference,
BRS, RR max and RR max/min at 50, 55, 60, 65, 70
and 75 years respectively (Table 2).
Agreement (in whole sample, n=631). The agreement
between the ten measures of autonomic function dif-
fered widely with correlation coefficients ranging
Fig. 3. Typical example of RR intervals (RRI) and systolic
blood pressure (SBP) changes during an active change (at
t=30 s) in posture from lying to standing. The three autonomic
function measures derived from this test are: RRmax,
RRmax/min and SBP difference, as is indicated by vertical ar-
rows
Table 1. Characteristics and measures of autonomic function
of the normotensive study sample (n=191) stratified by sex in a
healthy cohort aged 50 to 75 yearsa
Characteristics Male (n=98) Female (n=93)
Age (years) 62.0 (7.4) 63.3 (7.4)
BMI (kg/m2) 25.4 (2.5) 25.7 (3.5)
Fasting plasma glucose 5.45 (0.51) 5.31 (0.49)
(mmol/l)
HbA1c (%) 5.35 (0.50) 5.31 (0.43)
Cholesterol (mmol/l) 6.47 (1.04) 6.67 (1.18)
HDL Cholesterol (mmol/l) 1.22 (0.33) c 1.55 (0.32) c
Triglycerides (mmol/l) 1.61 (0.77) c 1.27 (0.60) c
Diastolic blood pressure 80 (7) c 77 (7) c
(mmHg)
Systolic blood pressure 128 (12) 128 (13)
(mmHg)
Autonomic function measures
Mean NN, ms 989 (15) 956 (14)
SDNN, ms b 36.5 (21.4–63.3) 35.4 (18.8–57.9)
LF power, ms2 b 354 (95–1002) c 213 (51–773) c
HF power, ms2 b 189 (44–995) 175 (34–964)
LF/(LF+HF), unitless 0.59 (0.02) 0.54 (0.02)
EI difference, ms b 207 (89–385) c 163 (73–291) c
BRS, ms/mmHg b 9.0 (4.5–15.4) 8.0 (4.3–14.4)
RR max, ms b 269 (154–410) 246 (162–365)
RR max/min, unitless b 1.24 (1.08–1.51) 1.24 (1.10–1.47)
SBP difference, mmHg –3.8 (1.6) –8.1 (1.6)
a Data are mean (standard deviation) unless otherwise indicat-
ed; b Given are the median (10 to 90th percentiles); c Male vs
female, p<0.05 after correction for age
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from –0.01 to 0.82 and, as assessed by applying the
reference values (Table 2) to the total sample
(n=631), the percentage of findings concordant for
autonomic dysfunction ranged from 0% to 87% (Ta-
ble 3). The agreement and correlation coefficient of
LF/(LF+HF) and SBP difference with all other auto-
nomic function measures were the lowest.
RRmax/min also showed a markedly low percentage
of concordance with the other measures, while Spear-
man’s correlation coefficients were moderate. For
Table 2. Reference values for the ten autonomic function pa-
rameters as a function of agea. Given are the 90%-prediction
intervals for individuals as estimated from a selected healthy
normotensive reference sample aged 50 to 75 (n=191). Also
given are the mean (SD) values for the healthy reference sam-
ple (second column)
Autonomic function measure Mean (SD) Age (years)
50 55 60 65 70 75
Mean NN, ms 973 (10) 5% 719 for all
95% 1189 for all
SDNN, ms b 36.2 (19.4–60.5) 5% 19.5 18.5 17.5 16.5 15.6 14.6
95% 82.3 77.4 72.9 68.8 65.1 61.7
LF power, ms2 b M 354 (95–1002) 5% 77 67 58 49 42 36
95% 2595 2204 1882 1614 1391 1205
F 213 (51–773) 5% 56 48 42 36 31 26
95% 1895 1607 1369 1172 1008 872
HF power, ms2 b 183 (39–965) 5% 48 38 31 25 20 15
95% 2422 1913 1518 1211 972 784
LF/(LF+HF), unitless 0.56 (0.01) 5% 0.26 for all
95% 0.85 for all
EI difference, ms b M 207 (89–385) 5% 101 92 83 75 68 61
95% 605 544 490 443 401 364
F 163 (73–291) 5% 84 76 69 62 56 51
95% 504 453 408 368 333 302
BRS, ms/mmHg b 8.8 (4.5–15.0) 5% 4.7 4.3 4.0 3.6 3.3 3.0
95% 24.3 22.0 20.0 18.3 16.7 15.3
RR max, ms b 256 (158–393) 5% 161 154 147 140 133 126
95% 492 467 445 424 404 386
RR max/min, unitless b 1.24 (1.09–1.49) 5% 1.13 1.09 1.06 1.03 1.00 0.97
95% 1.63 1.58 1.53 1.48 1.44 1.40
SBP difference, mmHg −5.8 (1.1) 5% −31 for all
95% 22 for all
a For three out of the ten autonomic function parameters no
(statistically) significant association with age was observed:
mean NN, LF/(LF+HF) and SBP difference. For SDNN, LF
power, HF power, EI difference, BRS, RR max and RR
max/min are reported at 50, 55, 60, 65, 70 and 75 years respec-
tively; b Ln transformed; given are the median (10th to 90th
centiles)
Table 3. Agreement between the measures of autonomic func-
tion in the complete sample of n=631. The upper right part
shows the Spearman correlation coefficients. The lower left
part gives the percentage of concordant grouping when apply-
ing the reference values (lowest 5th centile)
Autonomic Mean SDNN LF HF LF/ EI BRS RR RR max/ SBP 
function power Power (LF+HF) difference max min difference
measures
Mean NN 0.45 a 0.32 a 0.45 a −0.19 a 0.21 a 0.38 a 0.71 a 0.29 a 0.09 b
SDNN 42% 0.82 a 0.80 a −0.07 0.52 a 0.48 a 0.52 a 0.41 a 0.16 a
LF power 26% 56% 0.70 a 0.26 a 0.51 a 0.43 a 0.45 a 0.39 a 0.10 b
HF power 29% 56% 52% −0.46 a 0.49 a 0.43 a 0.48 a 0.40 a 0.13 a
LF/(LF+HF) 11% 6% 18% 2% −0.01 −0.02 −0.11 b −0.06 −0.04
EI difference 27% 50% 48% 37% 15% 0.69 a 0.35 a 0.33 a 0.08
BRS 48% 48% 38% 36% 14% 63% 0.37 a 0.31 a 0.06
RR max 87% 55% 41% 41% 7% 31% 31% 0.57 a 0.16 a
RR max/min 13% 15% 16% 13% 2% 17% 13% 18% 0.05
SBP difference 0% 11% 11% 3% 7% 8% 8% 3% 3%
a p <0.01; b p <0.05
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SDNN, LF power, HF power, EI difference, BRS and
RRmax agreement was good.
Reproducibility (in reproducibility sample, n=39). In a
subset of the Hoorn Study sample (n=36 to 38) from
which duplicate measurements were available, the
mean values, SD within subjects and SD between sub-
jects, reliability coefficient (RC) and coefficient of
variation (CV) were calculated for all autonomic func-
tion measures (Table 4). In general, reproducibility of
all parameters was moderate to high, with RCs rang-
ing from 43 to 93% and CVs ranging from 7 to 110%.
Mean NN and RRmax had the best reproducibility
with a RC over 85% and CV below 10%.
Discussion
This study shows data on age-specific and sex-specif-
ic reference values as well as reproducibility and mu-
tual agreement of ten measures of autonomic function
in adults aged 50 to 75 years. With the exception of
two, the agreement between the measures of autonom-
ic function was fairly good.
Reference values. This study, which is based on a
screening with repeated oral glucose tolerance tests in
a random sample from a well-defined general popula-
tion. It has, therefore, the major advantage of not in-
cluding subjects with impaired autonomic function
due to impaired glucose tolerance or undiagnosed 
diabetes mellitus. We excluded subjects with other
characteristics known to be associated with impaired
autonomic function, i.e. a history of cardiovascular
disease, hypertension and use of certain medication,
or neurological disease. Moreover, our sample
(n=191) includes a substantial number of subjects in a
high age category, which has been sparsely shown in
previous studies, despite its high relevance in view of
the common occurrence of Type 2 diabetes and its
complications in this age group. Furthermore, this is
the first large study in which three different categories
of autonomic function measures were studied simulta-
neously: Ewing-test measures, heart-rate variability
measures and baroreflex sensitivity.
The association between measures of autonomic
function and sex is consistent with previous findings:
women had lower values of autonomic function [9,
14, 15]. This association was both statistically and
clinically significant for LF power and EI difference
and appropriate sex-specific reference values were
given. Also, the association between measures of au-
tonomic function and age is consistent with previous
findings [8, 9, 10, 11, 12, 13], although we found
slightly lower associations with age. This could be at-
tributable to the older age of our subjects compared to
previous studies. Our study extends previous findings
in a sample of more advanced age.
It has been reported that high values of autonomic
function measures also have a predictive value in car-
diovascular disease; high values are associated with a
higher risk of cardiovascular disease [48]. Therefore,
we have provided both the lower and upper reference
values. We have computed the reference values on a
statistical basis, by taking the upper and lower five
percent of individual predictions on the basis of the
estimated variances. Ideally, one would define a cut-
off value on the basis of subjects who get the disease
and those who do not get the disease. In case of auto-
nomic neuropathy however, this is difficult since there
is no consensus about the diagnosis of the disease.
Nevertheless, several papers call for standardization
of measurements [1, 2]. Furthermore, the two distribu-
tion curves of the groups with and without the disease
are not likely to be completely separated, and some
statistical decision will have to be made eventually.
Therefore, the chosen statistical approach is the most
feasible with the current knowledge and consensus.
Of course it would be of utmost importance to use
the defined criteria to assess the prevalence and inci-
dence of autonomic dysfunction in the general popula-
tion. However, because the Hoorn Study is an age-,
sex- and glucose-tolerance-stratified cohort we were
not able to do this. Several other studies [26] would
Table 4. Reproducibility of ten measures of autonomic func-
tion in a sample of n=36, taken out of the complete sample of
n=631 of 50- to 75-year-old subjects, expressed as the SD
within subjects, SD between subjects, reliability coefficient
(RC), and coefficient of variation (CV)
Autonomic function measure N Mean a SD within SD between RC (%) CV (%)
Mean NN, ms 36 911 (185) 72 172 85 8
SDNN, ms 36 30.0 (12.9) 8.9 9.4 53 30
LF power, ms2 36 288 (298) 218 205 47 76
HF power, ms2 36 189 (201) 133 152 56 71
LF/(LF+HF), unitless 36 0.59 (0.17) 0.13 0.12 47 22
EI difference, ms 38 181 (101) 73 70 47 40
BRS, ms/mmHg 36 7.7 (3.4) 2.6 2.3 43 34
RR max, ms 36 209 (117) 30 114 93 14
RR max/min, unitless 36 1.22 (0.16) 0.09 0.13 71 39
SBP difference, mmHg 36 −9.76 (14.04) 10.71 11.82 55 110
provide excellent cohorts to apply these reference val-
ues. The predictive value for mortality and morbidity,
however, would be more informative, as well as longi-
tudinal observations on changes in autonomic function.
Agreement. The agreement, as assessed in the non-se-
lected sample of 631 subjects, varied greatly between
the different measures of autonomic function. One
prominent finding was the high agreement between
SDNN, LF power, BRS and EI difference with the
other measures of autonomic function.
The measures derived from the lying-to-standing
test, however, did poorly agree with the measures of
the other two tests. It could be that the lying-to-stand-
ing test depends, more than the other tests, on the 
patient’s co-operation or ability to exert effort. Espe-
cially in an elderly population this could be problemat-
ic, as is also shown by the higher number of missing
values for this test. Poor agreement between heart-rate
changes during deep breathing and after standing up
has also been reported in a study of 133 healthy sub-
jects in the age range of 10 to 65 years, where they
found a correlation between EI difference and RR max
of 0.17 and between EI difference and RR max/min of
0.14 [17]. An explanation might be the possible in-
volvement of different afferent and efferent mecha-
nisms [49]. For instance the RRmax/min measure ex-
presses the ratio of the relative bradycardia and the im-
mediate occurring tachycardia after standing up. While
the latter is almost exclusively determined by parasym-
pathetic withdrawal, the bradycardia is a rebound ef-
fect depending on the presence of a recovery (and
overshoot) of blood pressure by sympathetically medi-
ated vasoconstriction [50]. This makes the RRmax/min
ratio an autonomic function parameter expressing car-
diac vagal as well as (indirect) vasomotor sympathetic
functioning, while deep breathing heart rate changes
are almost exclusively vagally mediated. Similar argu-
ments as for the RRmax/min, hold for the systolic
blood pressure fall after standing up (SBP difference).
Moreover, SBP difference probably measures more
than just autonomic function, as the compliance of the
vascular (venous) system could play a role as well.
Another remarkable observation was the lack of
agreement between the spectral HRV power ratio, the
LF/(LF+HF) measure, and all other measures of auto-
nomic function. In 1986, it was suggested that the in-
stantaneous balance between sympathetic and vagal
nerve activities might be captured by a single number
[51]. This ratio, or so-called sympathovagal balance, has
been embraced by many others, because it would offer
“new possibilities for understanding dynamic, critically
important autonomic interrelations in humans by use of
totally non-invasive, unobtrusive means” [52]. Although
applied by many investigators in the field of autonomic
neural functioning, the concept of this balance with its
lack of a sound physiological basis, also has been seri-
ously criticized [53, 54]. Our results cast serious doubts
on this power ratio as a measure of autonomic function,
since it shows little to no agreement with any of the oth-
er measures of autonomic function.
Furthermore, we observed that measures obtained
from within the same test showed a higher agreement
than with those from another test. This is likely due to
the fact that these measures are obtained from the
same data set. For instance, the SDNN measure is
mathematically closely related to the spectral power
(the total power equals variance, which is by defini-
tion the squared standard deviation); so it is to expect
that the SDNN measure taken from the spontaneous
three minutes of HRV agrees relatively well with the
LF and HF power computed from this same three min-
utes of HRV data, which indeed it does, given the cor-
relation coefficients of 0.82 and 0.80, respectively.
We applied two different measures to express the
agreement between the autonomic function measures:
Spearman’s non-parametric correlation coefficients and
the percentage of agreement in subjects labelled as hav-
ing autonomic dysfunction based on the reference val-
ues. The latter gives additional information, since corre-
lation coefficient alone strictly speaking gives only the
strength of a relation between two variables and not the
agreement. [55] Both the correlation coefficients and the
percentages of agreement gave very similar results, indi-
cating that the agreement was similar not only in the
lower tail of the distribution, but over the entire range.
Reproducibility. In general, reproducibility, as assessed
in the subsample of 39 subjects, was moderate to high.
For example, the EI difference, the most frequently
used measure for autonomic function, had a RC of
47% and a CV of 40%. BRS and HRV measures
(SDNN, LF power, HF power) showed a comparable
reproducibility. These observations are roughly in line
with other studies. Best reproducibility was observed
for the Mean NN and the RR max with RCs over 85%
and CVs below 10%. The observed moderate repro-
ducibility could be partly attributable to the advanced
age of the subjects in two ways. Firstly, because lower
mean values are inherent to higher age which directly
leads to higher CVs (see methods section for formula).
Secondly, elderly people in general have more difficul-
ties to correctly carry out certain tests (deep breathing
and standing up quickly enough). This becomes appar-
ent when comparing our reproducibility with other
studies: somewhat higher reproducibility for the deep
breathing test (EI difference and BRS) for slightly
younger subjects [12, 56, 57, 58]. Reproducibility of
course might be improved by standardizing the condi-
tions during measurements [56]. In our study measure-
ments took place between 8:30 am and 4:00 pm. Since
there was no further standardization regarding time it
is possible that diurnal rhythm has influenced the re-
producibility to some extent. However it will not have
caused a systematic difference, since there was no sys-
tematic approach in the sequence of measurements
with respect to for example age or glucose tolerance.
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Schwartz PJ (1998) Baroreflex sensitivity and heart-rate
variability in prediction of total cardiac mortality after
myocardial infarction. Lancet 351:478–484
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Our reproducibility data are probably more indicative
of autonomic function testing in daily clinical practice
compared to “clean” laboratory studies and in that
sense might be more valuable.
Some earlier attempts have been made to compare
classic Ewing tests with some of the new HRV or
BRS in studies of autonomic dysfunction in mainly
Type 1 diabetes [4, 16, 20, 59]. This study is, howev-
er, the first that compares standard Ewing tests, HRV
as well as BRS within the same sample at an advanced
age and not restricted to diabetic patients. The correla-
tion coefficients and percentage concordance showed
that the agreement between the tests was not perfect.
This might on one hand be due to the moderate repro-
ducibility and on the other hand different measures
could (partly) measure different physiological sub-
strates. In the latter case some measures may be com-
plementary to each other. In view of these results it
would be recommended to use a combination of mea-
sures to assess autonomic dysfunction.
In conclusion, this study shows that the agreement
between eight out of ten measures of cardiovascular 
autonomic function varied greatly. Application of refer-
ence values of autonomic function may be considered
for testing autonomic function: age- and sex specific ref-
erence values are given for adults aged 50 to 75 years.
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